Archive | What We’re Reading
Early Estimations On National Take-Up From 2003 MMA And Future Policy Proposals
This technical report builds upon an existing effort supported by The Robert Wood Johnson Foundation. The objective of this analysis is to produce estimates of coverage and costs of alternative…
Accountable Care Organizations: Back to the Future?
Accountable Care Organizations (ACOs) are networks of providers that assume risk for the quality and total cost of the care they deliver. Public policymakers and private insurers hope that ACOs…
Favorable Selection, Risk Adjustment, and the Medicare Advantage Program
Payment generosity and more sophisticated risk adjustment were associated with substantial increases in MA enrollment and decreases in disenrollment. Claims experience of those newly switching into MA was not affected…
The Effects of Premium Changes on ALL Kids, Alabama’s CHIP Program
The increases in premiums and copays are estimated to have reduced program renewals by 6.1 to 8.3 percent depending upon how much time one allows for families to renew. Families…
Alternative Budgetary Analysis Of The Patient Protection And Affordable Care Act
The federal government faces a daunting fiscal outlook, which makes the budgetary impact of the Patient Protection and Affordable Care Act even more important. The official Congressional Budget Office (CBO)…
Medical Malpractice Reform and Employer-Sponsored Health Insurance
Using a variety of empirical specifications, there was no statistically significant evidence that noneconomic damage caps exerted any meaningful influence on the cost of employer-sponsored health insurance. The findings suggest…
Medicare Part D’s Effects on Elderly Patients’ Drug Costs & Utilization
Elderly patients’ utilization in the first year of Part D increased compared with that of near-elderly patients by 8.1% for days’ supply and 4.8% for the number of individuals filling…
How Similar Are States’ Medicaid Preferred Drug Lists?
For 42 (38%) of the drugs, there was wide consistency in PDL design, with at least 9 states classifying the drug with the same PDL status. For the other 62%…
Consumer Response To A National Marketplace For Individual Health Insurance
The objective of this analysis is to simulate the difference between national and state-specific individual insurance markets on take-up of individual health insurance. First, we reviewed the literature to characterize…
Hospital-Physician Gainsharing In Cardiology
The average in-lab cost per coronary stent patient increased from $3,338 in the fourth quarter of 2001 to $4,644 in the fourth quarter of 2006, and spending on devices and…